mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.0009 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |